Our country’s premier advocate for cost-benefit analysis has written about the coronavirus. He is Cass Sunstein, the Harvard law professor and former Obama White House regulatory guru. Of course you ...
This activity constitutes Phase 1 of a possible two-part effort directed towards guiding future benefit-cost studies, ensuring greater consistency and comparability across studies, and enhancing the ...
The coronavirus pandemic has forced governments to face excruciating trade-offs. Benefit-cost analysis is a standard framework for making policy trade-offs, and some have suggested that it be used to ...
Data plays a vital role in any successful business. Protecting this data is mission-critical, and it falls to database administrators (DBAs) to organize, maintain, and secure it. The most effective ...
The Environmental Protection Agency has published and solicited public comments on its draft rule reforming the benefit/cost analytic methodology applied to new regulations promulgated under the Clean ...
The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan. Objective: To ...
A large new global study of project performance over 86 years confirms that ingrained optimism bias results in forecast-based cost-benefit analyses "so misleading as to be worse than worthless," say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results